Moshe Talpaz Selected Research

Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)

5/2003

Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Moshe Talpaz Research Topics

Disease

97	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2024 - 01/2000
45	Philadelphia Chromosome 01/2023 - 02/2002
43	Neoplasms (Cancer) 04/2024 - 05/2003
43	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 03/2003
22	Leukemia 12/2021 - 03/2003
15	Thrombocytopenia (Thrombopenia) 05/2024 - 09/2002
12	Disease Progression 01/2024 - 03/2002
11	Splenomegaly 04/2024 - 10/2004
10	Anemia 01/2020 - 04/2002
9	Multiple Myeloma 12/2019 - 03/2003
8	Blast Crisis (Blast Phase) 01/2024 - 05/2002
8	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 06/2004
6	Fatigue 01/2023 - 06/2003
6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 06/2003
5	Fibrosis (Cirrhosis) 11/2023 - 07/2004
5	Neutropenia 01/2023 - 06/2003
4	Melanoma (Melanoma, Malignant) 02/2021 - 04/2007
4	Pancreatitis 12/2019 - 11/2012
3	Genetic Translocation (Chromosomal Translocation) 01/2017 - 04/2015
3	Diarrhea 01/2017 - 12/2003
3	Polycythemia Vera 08/2015 - 06/2003
3	Hematologic Neoplasms (Hematological Malignancy) 06/2013 - 02/2003
3	Chromosome Aberrations (Chromosome Abnormalities) 12/2010 - 05/2002
3	Residual Neoplasm 10/2007 - 01/2003
2	Squamous Cell Carcinoma of Head and Neck 02/2024 - 10/2005
2	Hypertension (High Blood Pressure) 01/2023 - 01/2016
2	Carcinoma (Carcinomatosis) 04/2021 - 01/2019
2	Wernicke Encephalopathy (Wernicke's Encephalopathy) 01/2021 - 07/2017
2	Nausea 01/2020 - 12/2003
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2020 - 02/2013
2	Inflammation (Inflammations) 01/2020 - 08/2003
2	Cytopenia 12/2019 - 05/2002
2	Exanthema (Rash) 01/2016 - 01/2016
2	Leukocytosis (Pleocytosis) 08/2015 - 12/2003
2	Essential Thrombocythemia 03/2011 - 06/2005
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2003 - 06/2003
2	Edema (Dropsy) 12/2003 - 08/2002
1	COVID-19 05/2024

Drug/Important Bio-Agent (IBA)

70	Imatinib Mesylate (Gleevec)FDA Link 10/2017 - 01/2000
27	ruxolitinibIBA 01/2024 - 03/2012
24	Tyrosine Kinase InhibitorsIBA 05/2024 - 01/2003
18	Phosphotransferases (Kinase)IBA 09/2023 - 01/2003
16	Proteins (Proteins, Gene)FDA Link 09/2023 - 03/2002
15	Interferon-alpha (Interferon Alfa)IBA 04/2015 - 01/2000
12	Janus Kinase InhibitorsIBA 04/2024 - 04/2013
11	fedratinibIBA 01/2024 - 03/2011
9	ponatinibIBA 01/2024 - 11/2012
9	bcr-abl Fusion ProteinsIBA 11/2013 - 01/2000
8	CytokinesIBA 01/2023 - 07/2003
7	InterferonsIBA 12/2021 - 06/2003
7	Dasatinib (BMS 354825)FDA Link 01/2018 - 10/2005
6	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 12/2010
6	Deubiquitinating EnzymesIBA 02/2021 - 11/2010
5	Lipase (Acid Lipase)FDA Link 05/2024 - 11/2012
5	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 04/2024 - 01/2018
5	Janus Kinase 2IBA 05/2021 - 12/2013
5	Transcription Factors (Transcription Factor)IBA 02/2021 - 08/2003
5	Janus Kinase 1IBA 01/2018 - 10/2013
5	degrasynIBA 06/2015 - 04/2007
5	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2005 - 05/2002
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 02/2008
4	Hemoglobins (Hemoglobin)IBA 11/2023 - 04/2002
4	Janus KinasesIBA 01/2022 - 03/2012
4	NF-kappa B (NF-kB)IBA 01/2021 - 08/2003
3	asciminibIBA 05/2024 - 12/2019
3	RNA (Ribonucleic Acid)IBA 04/2021 - 11/2011
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2021 - 07/2014
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020 - 11/2013
3	Erythropoietin FDA Link 10/2013 - 04/2002
3	Reticulin (Reticular Fiber)IBA 08/2005 - 07/2004
2	CalreticulinIBA 04/2024 - 01/2021
2	Thrombopoietin ReceptorsIBA 04/2024 - 01/2021
2	EnzymesIBA 01/2023 - 02/2021
2	LigandsIBA 10/2019 - 12/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2019 - 08/2003
2	glasdegibIBA 06/2019 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 02/2002
2	nilotinib FDA Link 01/2018 - 01/2007
2	INCB039110IBA 01/2018 - 01/2017
2	Proteasome InhibitorsIBA 01/2016 - 08/2014
2	marizomibIBA 01/2016 - 08/2014
2	Bortezomib (Velcade)FDA Link 08/2014 - 10/2009
2	UbiquitinIBA 12/2011 - 08/2011
2	Tyrosine (L-Tyrosine)FDA Link 04/2008 - 10/2005
2	Protein Isoforms (Isoforms)IBA 12/2006 - 01/2004
2	TransferasesIBA 01/2006 - 03/2003
2	Decitabine FDA Link 06/2005 - 08/2003
2	tipifarnib (R115777)IBA 12/2003 - 03/2003
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2003 - 02/2002
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2003 - 07/2003
2	HomoharringtonineIBA 09/2003 - 04/2002
1	Circulating Tumor DNAIBA 02/2024
1	navitoclaxIBA 01/2024

Therapy/Procedure

89	Therapeutics 04/2024 - 04/2002
4	Drug Tapering 01/2018 - 06/2003
3	Stem Cell Transplantation 07/2003 - 09/2002
2	Cell Transplantation 12/2021 - 12/2020
2	Precision Medicine 09/2015 - 03/2008
2	Drug Therapy (Chemotherapy) 12/2006 - 03/2005
2	Aftercare (After-Treatment) 02/2003 - 08/2002